Senescence and cancer: a review of clinical implications of senescence and senotherapies
L Wyld, I Bellantuono, T Tchkonia, J Morgan, O Turner… - Cancers, 2020 - mdpi.com
Cellular senescence is a key component of human aging that can be induced by a range of
stimuli, including DNA damage, cellular stress, telomere shortening, and the activation of …
stimuli, including DNA damage, cellular stress, telomere shortening, and the activation of …
Senescent cells: SASPected drivers of age-related pathologies
Y Ovadya, V Krizhanovsky - Biogerontology, 2014 - Springer
The progression of physiological ageing is driven by intracellular aberrations including
telomere attrition, genomic instability, epigenetic alterations and loss of proteostasis. These …
telomere attrition, genomic instability, epigenetic alterations and loss of proteostasis. These …
Targeting senescent cells: possible implications for delaying skin aging: a mini-review
MC Velarde, M Demaria - Gerontology, 2016 - karger.com
Senescent cells are induced by a wide variety of stimuli. They accumulate in several tissues
during aging, including the skin. Senescent cells secrete proinflammatory cytokines …
during aging, including the skin. Senescent cells secrete proinflammatory cytokines …
[HTML][HTML] Musculoskeletal senescence: a moving target ready to be eliminated
MP Baar, E Perdiguero, P Munoz-Canoves… - Current opinion in …, 2018 - Elsevier
Highlights•Cellular senescence drives age-related decline of the musculoskeletal
system.•The Senescence Associated Secretory Phenotype (SASP) can chronically impair …
system.•The Senescence Associated Secretory Phenotype (SASP) can chronically impair …
The essence of senescence
T Kuilman, C Michaloglou, WJ Mooi… - Genes & …, 2010 - genesdev.cshlp.org
Almost half a century after the first reports describing the limited replicative potential of
primary cells in culture, there is now overwhelming evidence for the existence of “cellular …
primary cells in culture, there is now overwhelming evidence for the existence of “cellular …
Therapeutic potential of senolytics in cardiovascular disease
Ageing is the biggest risk factor for impaired cardiovascular health, with cardiovascular
disease being the leading cause of death in 40% of individuals over 65 years old. Ageing is …
disease being the leading cause of death in 40% of individuals over 65 years old. Ageing is …
Beyond tumor suppression: senescence in cancer stemness and tumor dormancy
F Triana-Martínez, MI Loza, E Domínguez - Cells, 2020 - mdpi.com
Here, we provide an overview of the importance of cellular fate in cancer as a group of
diseases of abnormal cell growth. Tumor development and progression is a highly dynamic …
diseases of abnormal cell growth. Tumor development and progression is a highly dynamic …
Strategies for senolytic drug discovery
Senolytics are a category of drugs that reduce the impact of cellular senescence, an effect
associated with a range of chronic and age‐related diseases. Since the discovery of the first …
associated with a range of chronic and age‐related diseases. Since the discovery of the first …
Cellular aging beyond cellular senescence: Markers of senescence prior to cell cycle arrest in vitro and in vivo
M Ogrodnik - Aging cell, 2021 - Wiley Online Library
The field of research on cellular senescence experienced a rapid expansion from being
primarily focused on in vitro aspects of aging to the vast territories of animal and clinical …
primarily focused on in vitro aspects of aging to the vast territories of animal and clinical …
[HTML][HTML] Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls
Ageing is the biggest risk factor for impaired cardiovascular health, with cardiovascular
disease being the cause of death in 40% of individuals over 65 years old. Ageing is …
disease being the cause of death in 40% of individuals over 65 years old. Ageing is …